EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Economic outcomes associated with acute interstitial pneumonia in Central U.S. High Plains feedyards

Merri E Day, Dustin L Pendell, Brad J White, Phillip A Lancaster, Robert L Larson

Translational Animal Science · 2025-01-07 · 9

DOI: 10.1093/tas/txaf091 ↗
AbstractBibliografische Angaben

Abstract

Abstract The objective of this study was to evaluate net returns for Central U.S. high plains feedyard cattle identified with acute interstitial pneumonia (AIP) ante-mortem and postmortem (n = 5,339) and to examine economic outcomes across sex, placement weight, and number of AIP treatments. A decision tree framework was implemented to estimate net returns of cattle identified with AIP, where decision nodes represented choices made by the producer, and branches represented potential outcomes following a decision. The initial decision node was whether to treat cattle for AIP after the first identification for illness or to sell (cull) soon after diagnosis at reduced weight and price compared to cattle in the cohort sold at finished weight. Following initial treatment, cattle that remained in the feedyard either finished (with or without further treatment), were culled, or died after additional diagnosis and treatment. Probabilities of incidents at each node were obtained from the data distribution. This research indicates that estimated net returns for feedyard cattle identified with AIP vary by sex, placement weight, and number of AIP treatments. The expected net return to feeding healthy cattle was $193.67/animal, while the expected net return for cattle that finished after AIP treatment was -$639.71/animal for cattle treated once for AIP, -$612.41/animal for those treated twice for AIP, and -$529.57/animal for those treated three or more times for AIP. However, other health indicators and risk factors not included in this analysis should be considered when deciding whether to keep or cull feedyard cattle identified with AIP.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →